- Bioniche E. coli O157:H7 Cattle Vaccine Authorized for Field Use in Canada
Bioniche Life Sciences Inc. received authorization from the CFIA to distribute its E. coli O157:H7 cattle vaccine to Canadian veterinarians under a Permit to Release Veterinary Biologics as specified in the Canadian Health of Animal Regulations.
- U of S VIDO team discovers key step in flu virus replication
As public health officials around the world keep a nervous eye on the spread of avian influenza, the University of Saskatchewan's Vaccine and Infectious Disease Organization has uncovered a key step in how the influenza virus causes infection.
- International Centre for Infectious Diseases Names New Board Chair
Dr. Lorne Babiuk, Director and CEO of Saskatoon’s VIDO and Canada Research Chair in Vaccinology and Biotechnology, takes over the role from the Board’s founding chair, Dr. Stephen Moses of the University of Manitoba.
- Maternal Immunization May Protect Newborns from Whooping Cough U of S VIDO Study
In a bid to find a way to protect newborns from whooping cough, a research team at the University of Saskatchewan’s Vaccine and Infectious Disease Organization has shown that vaccinating pregnant sows may control the disease in newborn piglets.
- Lorne Babiuk invested into Order of Canada
The head of the Vaccine and Infectious Disease Organization (VIDO) was invested as an officer in the Order of Canada on Friday.
- Dr. Paul Hodgson joins VIDO as Associate Director of Business Development
VIDO is pleased to announce that Dr. Paul Hodgson has joined the Senior Management Team as Associate Director of Business Development as of Jan.1, 2006
- U of S Researchers Develop New Vaccine Candidate Against Hepatitis C
Researchers at the University of Saskatchewan’s Vaccine and Infectious Disease Organization have developed a vaccine candidate for hepatitis C, leading to hope in the fight against a disease for which no vaccines are yet available.